International
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System. The Company plans to launch the TAXUS Liberté stent early next month in the United States, following completion of the introduction of its TAXUS® Expresss2™ Atom™ Paclitaxel-Eluting Coronary Stent System, which was approved by the FDA last month. The TAXUS Liberté stent was launched in Europe and other international markets in 2005.
To view Multimedia News Release go to, http://www.prnewswire.com/mnr/bsci/34446/
Rated 4.43 | 1,373 Views
Affiliate Submitter: drrufusrajadurai
Rated 4.50 | 754 Views
Affiliate Submitter: baqaians
Rated 4.39 | 906 Views
Affiliate Submitter: nucleusanimation
PreOp® Coronary Artery Bypass CABG) Patien...t Education
Rated 4.39 | 1,329 Views
Affiliate Submitter: PreOpcom
Rated 4.17 | 1,795 Views
Affiliate Submitter: hungari8369
Beating Heart Totally Endoscopic Coronary...Artery Bypass
Rated 3.85 | 1,245 Views
Affiliate Submitter: ORLivedotcom
Rated 2.75 | 589 Views
Percutaneous Transluminal Coronary Angiopl...asty
Rated 4.50 | 364 Views
Affiliate Submitter: focusmedica
Total Arterial Awake Off Pump Coronary Art...ery Bypass Grafting (CABG)
Rated 0.00 | 315 Views
Affiliate Submitter: kshitijdubey1974
Coronary Heart Failure Patients See Improv...ement W/Stem Cells
Rated 0.00 | 45 Views
By Qateid
Rated 0.00 | 20 Views
By MultiVu
Over and Under Pericardium Covered Stent
Rated 4.50 | 281 Views
Affiliate Submitter: dannam10
Rated 4.50 | 239 Views
Affiliate Submitter: nursegwadz
Florent Pagny - Ma Liberté De Penser
Rated 4.28 | 3,261 Views
Affiliate Submitter: epingchris
Rated 4.36 | 417 Views
Affiliate Submitter: madkrull
L'Espérance : Liberté Egalité Fraternité
Rated 3.83 | 53 Views
Affiliate Submitter: otnet